Aurora Cannabis Inc
Aurora Cannabis Inc. is a publicly traded cannabis and medical marijuana producer based in Edmonton, Canada. The company operates in 24 countries on 5 continents and is the third largest group in the industry in terms of market capitalization (behind Canopy Growth and Aphria).
Aurora Cannabis Inc. (NYSE: ACB) stocks lagged the S&P 500 in 2021, down 14.9% overall year-to-date.
Aurora stock has been on a wild ride in 2021, but investors may be wondering if Aurora stock still has any value at all.
Aurora actually performed weaker than in the corresponding period of the previous year in terms of sales. Income was 54.8 million Canadian dollars, compared to 67.5 million Canadian dollars a year earlier. However, the loss could be significantly reduced, which was well received by investors. The EBITDA for the past quarter was minus 106 million Canadian dollars. In the same period last year there was a loss of 1.85 billion Canadian dollars.
The corona crisis with its consequences and side effects has hit the cannabis traders badly. In this essentially reduced-contact world, it was difficult for this industry to get good business. Thanks to Joe Biden and Co, cannabis stocks like Aurora Cannabis saw some kind of rebirth in November. The question that investors are now asking themselves: Where is the journey for the Canadian cannabis producer’s paper going.
Trade Team Forecast
The Aurora Cannabis share is one of the risky stocks. Being legal or not legal determines the value. We can only recommend this share to shareholders who like to play aggressively. What is very important, you should always have an overview of the stock.
Tip: If you have a good profit, sell the share immediately!